Evidence map›Paper›PMID 20671593›Full record

ReviewTransplantation2010

Pleiotropic effects of transforming growth factor-β in hematopoietic stem-cell transplantation.

Stephanie M Coomes, Bethany B Moore

Open access · greenAbstract readReview
In one paragraph

Review in Transplantation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. iScience · 2022
    Article
  5. Review
  6. Blood Platelets as an Important but Underrated Circulating Source of TGFβ.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stephanie M CoomesUniversity of Michigan Program in Biomedical Sciences, Ann Arbor, MI, USA.
Bethany B Moore
University of Michigan–Ann Arbor · US

Funding

RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
PGE2 Regulation of Host Defense post-BMTR01AI065543 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2007 to 2011
$1.9M
Herpesvirus infection/injury govern fibrocyte recruitment and activationR01HL087846 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2008 to 2011
$1.5M
HSCT-induced changes that impair lung innate immunityR56AI065543 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2012 to 2012
$363k
NHLBI NIH HHS HL087846NHLBI NIH HHS R01 HL087846NIAID NIH HHS AI065543NIAID NIH HHS R01 AI065543NIAID NIH HHS R56 AI065543NIAID NIH HHS T32 AI007413
6 · The paper itself

Abstract

Transforming growth factor (TGF)-β is a pleiotropic cytokine with beneficial and detrimental effects posthematopoietic stem-cell transplantation. TGF-β is increased in specific sites postengraftment and can suppress immune responses and maintain peripheral tolerance. Thus, TGF-β may promote allograft acceptance. However, TGF-β is also the central pathogenic cytokine in fibrotic disease and likely promotes pneumonitis. Although TGF-β can enhance leukocyte recruitment and IgA production, it inhibits both innate and adaptive immune cell function and antiviral host defense posthematopoietic stem-cell transplantation. This review will focus on the current understanding of TGF-β biology and the numerous ways it can impact outcomes posttransplant.

Indexed as

Hematopoietic Stem Cell TransplantationAnimalsCell SurvivalGraft RejectionGraft SurvivalGraft vs Host DiseaseHematopoietic Stem CellsHumansPulmonary FibrosisTime FactorsT-Lymphocytes, RegulatoryTransforming Growth Factor betaTransplantation, HomologousTransplantation ToleranceTreatment OutcomeTransforming Growth Factor beta

Identifiers

PMID20671593
PMCPMC2995826
OpenAlexW2070451750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.